In sum, long-term SSEs beneath the Kii Channel were spatiotemporally variable.
Finally, we built a CUDA kernel to process the last part of Algorithm 4 (quantity of maximum subsequence sum, longest subsequence, and shortest subsequence).
In the last step, each GPU sends its three values (quantity of maximum subsequence sum, longest subsequence, and shortest subsequence) to the host that will compute the final solution.
A partial response (PR) is at least a 30% decrease in the sum of the longest diameter of target lesions, taking as reference the baseline sum longest diameter.
Partial response (PR): 30% or greater decrease in the sum of the longest diameter of target lesions, taking as reference the baseline sum longest diameter.
Progressive disease (PD): At least 20% increase in the sum of the longest diameter of target lesions, taking as reference the baseline sum longest diameter, or the appearance of new lesions and/or unequivocal progression of existing non-target lesions.
Associations between the Response Evaluation Criteria in Solid Tumors (RECIST) baseline sum longest diameter (BSLD), response rate, progression-free survival (PFS) and overall survival (OS) were evaluated using univariate and multivariable Cox regression models.
Stable disease (SD): Neither sufficient shrinkage to qualify for partial response nor sufficient increase to qualify for progressive disease, taking as reference the smallest sum longest diameter from the start of treatment.
Stable disease is neither sufficient shrinkage for a partial response, nor sufficient increase to qualify for progressive disease, taking as reference the smallest sum longest diameter since the treatment started.
We therefore analysed the association between the Response Evaluation Criteria in Solid Tumors (RECIST) baseline sum longest diameter (BSLD) and clinical outcomes in a recent phase 3 Eastern Cooperative Oncology Group (ECOG) trial for advanced NSCLC, E4599.
In the assessment of the best overall response, a complete response (CR: the disappearance of all lesions and normalization of tumor marker level) or partial response (PR: at least a 30% decrease in the sum of the longest diameter of all measured lesions taking as reference the baseline sum longest diameter) had to continue for at least 4 weeks and to be confirmed.
